For research and educational purposes only. Not medical advice.
Pegvisomant Reference
Educational, not medical advice reference for Pegvisomant: Hormonal; regulatory status, evidence posture, source review, and schedule notes. Also known as So…
Reference summary
Pegvisomant has label-verified evidence in acromegaly. pepSmart surfaces label-reference content only and is not a prescribing tool.
- Categories
- Hormonal
- Aliases
- Somavert, GH receptor antagonist
- Evidence posture
- human
- Regulatory status
- FDA-approved prescription medication (Somavert). Labeled for acromegaly in adults who have had an inadequate response to surgery and/or radiation therapy, or for whom these therapies are not appropriate. pegvisomant is a GH receptor antagonist, pharmacologically opposite to GH-axis secretagogues.
- Content review status
- label verified